Many studies have shown that mutations and abnormal expression of the FANCD1 and FANCD2, two major genes in the Fanconi anemia pathway, are significantly associated with poor prognosis of CCA [42]. The gene discussed is BRCA2; the disease is cholangiocarcinoma.